SCHEMBL19273656

SCHEMBL19273656

CO[C@H]1O[C@H](COC(=O)[C@H](C)[C@@H](C)O)[C@@H](O)[C@@H]1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKD3 O94806 1/20 0.45
▸ PRKCG P05129 1/20 0.45
▸ PRKCB P05771 1/20 0.45
▸ PRKCA P17252 1/20 0.45
▸ PRKCH P24723 1/20 0.45
▸ PRKCI P41743 1/20 0.45
▸ PRKCE Q02156 1/20 0.45
▸ PRKCQ Q04759 1/20 0.45
▸ PRKCZ Q05513 1/20 0.45
▸ PRKCD Q05655 1/20 0.45
▸ PRKD1 Q15139 1/20 0.45
▸ TLR4 O00206 1/20 0.40
▸ G6PD P11413 3/20 0.39
▸ CA1 P00915 3/20 0.38
▸ CA2 P00918 3/20 0.38
▸ CA9 Q16790 3/20 0.38
▸ XDH P47989 1/20 0.37
▸ LGALS8 O00214 2/20 0.37
▸ LGALS3 P17931 1/20 0.36
▸ MMP9 P14780 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18513195 0.87 FGF1 (0.39) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL22446829 0.83 TLR4 (0.47) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL6129350 0.82 PRKD3 (0.48) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL20976854 0.81 TLR4 (0.36) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL18513306 0.81 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL22446825 0.79 TLR4 (0.41) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL10291154 0.79 PRKD3 (0.43) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL2320839 0.78 PRKD3 (0.46) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL14175697 0.78 PRKD3 (0.46) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL7146273 0.78 PRKD3 (0.46) PRKD3PRKCGPRKCBPRKCAPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11162944-B2 Compositions and methods Diagnostig LTD. (GB) 2021-11-02 — — US disclosed
US-10809260-B2 Method and kit for detection of mycobacteria DIAGNOSTIG LTD (GB) 2020-10-20 — — US disclosed
US-20170242005-A1 METHOD AND KIT FOR DETECTION OF MYCOBACTERIA BANGOR UNIVERSITY (GB) 2017-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11162944-B2 Compositions and methods CD14, CD63, CD44 PRKD3 4506/4885PRKCG 3345/4885PRKCB 3358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback